Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

  • 00:30

    Crowd Funding Resources 2016

    in Internet

    This program will be featuring my just released white paper Crowd Funding Resources 2016. We will be highlighting the latest and greatest resources and sources for crowd funding covering search engines, subject directories, articles, guides and tracers....literally everything CROWD FUNDING on the Internet!!!! We will also discussing my latest freely available Awareness Watch Newsletter V12N12 December 2015 featuring ShoppingBots and Online Shopping 2015 and my freely available December 2015 Zillman Column highlighting 2016 Directory of Directories. You may call in to ask your questions at (718)508-9839. The show is live and thirty minutes in length starting at 2:00pm EST on Wednesday, December 9, 2015 and then archived for easy review and access. Listen, Call and Enjoy!!

  • 01:01

    Heather Wilson Effective Crowd-funding & Kathy Strahan Optimize Your Health

    in Entrepreneur

    Heather Wilson, cofounder of the #1 FREE Christian Crowdfunding site called GiveSendGo.com . Heather reveals how to effectively use crowd funding  and how to create a successful campaign.  GiveSendGo.com


    Kathy Strahan shares her unique story as a successful totally blind person. She has always been a teacher at heart.Kathy inspires those around her to be their best selves. You see, Kathy has been totally blind since age two. Clearly she faces life with great courage. KathyStrahan.com and www.theglutenfreegirls.com


    Here is the cook big freeze small concept outlined and fully described in our interview.


    The recipe for the chocolate banana pops:



  • 00:48

    ALS Crowd Radio: Dr. Merit Cudkowicz, MD, on Progress Since Ice Bucket Challenge

    in Health

    Dr. Merit Cudkowicz will kick off ALS Crowd Radio Season 2 with an overview of the state of ALS research and treatment today.  As director of MDA ALS Clinic at Massachusetts General Hospital and Professor of Neurology at Harvard Medical School, Dr. Cudkowicz is involved in every aspect of ALS research and treatment including: diagnosing and treating patients, clinical trials, research projects, and the search for a biomarker.  She will give an overarching view of what is happening in this constantly progressing field and what it means for ALS patients.

  • 01:12

    Myeloma Crowd Radio: Melanie House, DPT, NCS, University of Iowa

    in Health

    Melanie House, DPT, NCS of the University of Iowa recently presented at Pat's Myeloma Survival School on physical issues that myeloma patients face before, during and after their treatment. As part of the Muscles for Myeloma series, she will give practical, real-world advice to make life more manageable for patients:

    How to rebuild strength during and after treatment and how dex and bedrest waste muscles
    How to prevent falls and improve balance
    How to manage peripheral neuropathy
    How to increase endurance
    How to overcome that "so tired" feeling of fatigue post-treatment
    What to do about shortness of breath
    How to decrease back pain, muscles spasms and nerve pain

    Thanks to our episode sponsor, Takeda Oncology

    Thanks also to our Muscles for Myeloma sponsors: Sanofi Genzyme, Takeda Oncology and Celgene Corporation

  • 00:47

    ALS Crowd Radio: Dr. Joseph Beckman, Ph.D., Oregon State U: Stopping ALS in Lab

    in Health

    S2:E2 Dr. Joseph Beckman, Ph.D. will speak about his research findings that have essentially stopped the progressions of ALS for nearly two years in one type of mouse model used to study the disease.  This has allowed the mice to approach their normal lifespan.  The new therapy uses a copper-ATSM compound.  The findings of the study were published in the journal of Neurobiology of Disease in Jan 2016.  Joseph Beckman is a distinguished professor of biochemistry and biophysics in the College of Science at Oregon State University, and principal investigator and holder of the Burgess and Elizabeth Jamieson Chair in OSU’s Linus Pauling Institute.  He will explain the study, what will come next in the research process, and what this means for ALS patients.

  • 00:55

    ALS Crowd Radio: Dr. Paul Cox, PhD, Environmental Causes of ALS

    in Health

    S2:E3 Dr. Paul Alan Cox, Ph.D., Director of the Institute for Ethnomedicine, will speak about his research in finding and fighting the environmental causes of ALS.  Dietary exposure to an environmental toxin called BMAA may trigger ALS related symptoms.   Large doses of the dietary amino acid called L-serine may reduce the risk of BMAA exposure.  Dr. Cox published his most recent findings in the Proceedings of the British Royal Society published on Jan 20, 2016.

    A Harvard Ph.D., Paul Alan Cox has spent his career searching for new medicines by studying patterns of wellness and disease among indigenous peoples. For these efforts, TIME magazine named Cox one of 11 “Heroes of Medicine.” His work with indigenous peoples in preserving their island rain forests won him the Goldman Environmental Prize. Cox has published over 200 scientific papers and four books.

    He has held academic appointments at the University of California, Berkeley, Brigham Young University, the University of Melbourne, Uppsala University, the Swedish Agricultural University, and the University of Illinois, Chicago, and served as Director of the Congressionally-chartered National Tropical Botanical Gardens in Hawaii and Florida.

    Cox founded Seacology, the world’s premier environmental non-profit organization for island conservation, headquartered in Berkeley, California. Through partnerships with indigenous people, Seacology has now saved over 1.3 million acres of island rainforests and coral reefs in 56 nations. Throughout Polynesia, he is known by the chiefly title Nafanua.

    Cox currently serves as the Executive Director of the Institute for Ethnomedicine in Jackson Hole, Wyoming. His research there is focused on finding and fighting the causes of neurodegenerative disease including ALS and Alzheimer’s disease.



  • 00:14

    Crowd Funding Terms

    in Business

    Are you confused by all the different crowd funding terms you hear thrown around? After today's show you will be clear on what's what!
    Our featured project is the Flamio lamp
    Learn more at Get Crowd Funded Now

  • 00:27

    The Legal Show: And the Crowd(funding) Goes Wild!

    in Legal

    Attorney Sarah Avraham and writer Bennet Pomerantz discuss the subjects of the day.
    The audience should know that although Ms. Avraham is a licensed attorney, she is not offering legal advice in any capacity, is not establishing an attorney/client relationship with anyone listening to the show, and recommends that any listener of the show consult a local attorney for any legal advice they may require.
    This show is about us discussing hot topics and how they relate to the law.
    In December, a lawsuit was filed in California federal court against the creators and producers of a new Star Trek film, Axanar.  Axanar is a feature film that is preceded by a short film.  So what is so different about it?  It has been made possible by $1 million in crowdfunding via Kickstarter and Indiegogo.  So why is Paramount suing now when so many Star Trek sourced fan fiction and movies have been made and distributed?  Tune in to the Legal Show to find out.


  • 01:10

    Myeloma Crowd Radio: Dr. David Siegel, MD, PhD, John Theurer Cancer Center

    in Health

    The multiple myeloma aresenal is growing, giving myeloma experts more tools to combat the complex blood cancer, multiple myeloma. Learn how investigators like Dr. David Siegel, MD, PhD of the John Theurer Cancer Center are vetting treatment combinations using clinical trials to identify optimal treatment paths, especially for patients who are facing relapses or who have become refractory to existing medications. 

    Thanks to our episode sponsor, Takeda Oncology.

  • 01:00

    Myeloma Crowd Radio: Dr. David Avigan, MD, Beth Israel Deaconess Medical Center

    in Health

    Immunotherapy combinations are just beginning. At the ASH 2015 conference Dr. David Avigan, MD of the Beth Israel Deaconess Medical Center shared his work to use a vaccine with an additional immunotherapy (a PD-1 blocker) and autologous transplant to make the transplant more durable and eliminate minimal residual disease. Learn more about this dendritic cell vaccine, how it works and why the road to immunotherapy will leverage the best available treatments for the best ultimate outcomes. 

    Thanks to our episode sponsor, Takeda Oncology.

  • 00:01

    Crowd funding Your business

    in Business

    Dr. Wright talks about crowd funding success and 
    the To Proove Him Wrong Campaign at